Pharmaceutical composition and process for the preparation thereof
US5589513A · kind A · utility
34Cited by
4References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 1994 |
| Grant date | Dec 31, 1996 |
| Priority date | — |
| Expiry date | Jun 17, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to two phase pharmaceutical compositions comprising as active ingredient a MAO inhibitor and an uptake inhibitor together with usual pharmaceutical auxiliaries. The compositions can be used for the treatment of neurodegenerative diseases. As active ingredient optionally N-(1-phenyl-isopropyl)-N-methyl-propinylamine or N-(4-fluoro-phenyl)-isoprop-1-yl-N-methyl-propinylamine or their salts, optically active isomers or metabolites are used both as MAO inhibitor and as uptake inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.